Product approvals

The Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...

  Bayer’s high dose aflibercept 8 mg – now approved in the European Union and US – has been labelled...

Bayer’s higher dose aflibercept 8 mg with extended treatment intervals is set for approval in the European Union (EU) for...

The US Food and Drug Administration (FDA) has issued product warnings for an additional 27 over-the-counter eyedrop products due to...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...

The US Food and Drug Administration (FDA) has approved a second therapy for geographic atrophy (GA), with IZERVAY (avacincaptad pegol...

Medtech company Eyerising International Pty Ltd has announced its myopia management device – based on repeated low-level red-light (RLRL) technology...

In a historic first, the US Food and Drug Administration (FDA) has approved SYFOVRE (pegcetacoplan injection), manufactured by global biopharmaceutical...

The Therapeutic Goods Administration (TGA) has approved a new AI software system that can screen for three major eye diseases...

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children...